Connection

Matthew Carpenter to Middle Aged

Back to Details
This is a "connection" page, showing publications Matthew Carpenter has written about Middle Aged.
Matthew Carpenter
Connection Strength
1.312
Middle Aged
  1. The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):880-886.
    View in: PubMed
    Score: 0.049
  2. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.049
  3. Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
    View in: PubMed
    Score: 0.045
  4. Longer duration of smoking abstinence is associated with waning cessation fatigue. Behav Res Ther. 2019 04; 115:12-18.
    View in: PubMed
    Score: 0.045
  5. ?Apt?vate!: A Spanish-language behavioral activation mobile application for delivery via primary care. Psychol Serv. 2019 May; 16(2):271-275.
    View in: PubMed
    Score: 0.045
  6. Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. J Consult Clin Psychol. 2018 Nov; 86(11):903-914.
    View in: PubMed
    Score: 0.045
  7. State Tobacco Policies as Predictors of Evidence-Based Cessation Method Usage: Results From a Large, Nationally Representative Dataset. Nicotine Tob Res. 2018 09 25; 20(11):1336-1343.
    View in: PubMed
    Score: 0.044
  8. One-Year Smoking Trajectories Among Established Adult Smokers With Low Baseline Motivation to Quit. Nicotine Tob Res. 2017 Dec 13; 20(1):50-57.
    View in: PubMed
    Score: 0.042
  9. Perceptions of Snus Among US Adult Smokers Given Free Product. Nicotine Tob Res. 2017 Dec 13; 20(1):22-29.
    View in: PubMed
    Score: 0.042
  10. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.042
  11. Development and initial validation of a cessation fatigue scale. Drug Alcohol Depend. 2017 07 01; 176:102-108.
    View in: PubMed
    Score: 0.040
  12. Effectiveness of Switching Smoking-Cessation Medications Following Relapse. Am J Prev Med. 2017 Aug; 53(2):e63-e70.
    View in: PubMed
    Score: 0.040
  13. A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
    View in: PubMed
    Score: 0.038
  14. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus. Addict Behav. 2016 12; 63:82-8.
    View in: PubMed
    Score: 0.038
  15. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers. Tob Control. 2017 03; 26(2):202-209.
    View in: PubMed
    Score: 0.038
  16. Prevalence of cigarette smoking and attempts to quit in a population-based cohort with spinal cord injury. Spinal Cord. 2015 Aug; 53(8):641-5.
    View in: PubMed
    Score: 0.035
  17. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction. Psychol Addict Behav. 2015 Jun; 29(2):392-9.
    View in: PubMed
    Score: 0.034
  18. Impact of a brief telephone referral on quitline use, quit attempts and abstinence. Health Educ Res. 2015 Feb; 30(1):134-9.
    View in: PubMed
    Score: 0.033
  19. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
    View in: PubMed
    Score: 0.032
  20. Characteristics of cigarette smokers who want to quit now versus quit later. Addict Behav. 2013 Jun; 38(6):2257-60.
    View in: PubMed
    Score: 0.030
  21. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012 Aug; 20(4):251-7.
    View in: PubMed
    Score: 0.029
  22. Predictors of quit attempts and abstinence among smokers not currently interested in quitting. Nicotine Tob Res. 2012 Oct; 14(10):1197-204.
    View in: PubMed
    Score: 0.028
  23. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011 Nov 28; 171(21):1901-7.
    View in: PubMed
    Score: 0.028
  24. Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc. 2011 Sep-Oct; 103(9-10):885-94.
    View in: PubMed
    Score: 0.027
  25. 'Closet' quit attempts: prevalence, correlates and association with outcome. Addiction. 2011 Dec; 106(12):2214-20.
    View in: PubMed
    Score: 0.027
  26. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res. 2011 Aug; 13(8):646-52.
    View in: PubMed
    Score: 0.026
  27. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res. 2010 Feb; 12(2):136-43.
    View in: PubMed
    Score: 0.024
  28. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med. 2007 Feb; 33(1):22-8.
    View in: PubMed
    Score: 0.020
  29. Daily adherence to nicotine replacement therapy in low-income smokers: The role of gender, negative mood, motivation, and self-efficacy. Addict Behav. 2023 03; 138:107543.
    View in: PubMed
    Score: 0.015
  30. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
    View in: PubMed
    Score: 0.015
  31. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
    View in: PubMed
    Score: 0.013
  32. A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial. Nicotine Tob Res. 2021 05 24; 23(6):1064-1067.
    View in: PubMed
    Score: 0.013
  33. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
    View in: PubMed
    Score: 0.012
  34. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.012
  35. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.012
  36. Delivery and implementation of an algorithm for smoking cessation treatment for people living with HIV and AIDS. AIDS Care. 2020 02; 32(2):223-229.
    View in: PubMed
    Score: 0.012
  37. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275.
    View in: PubMed
    Score: 0.011
  38. Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Mar 01; 74(3):214-223.
    View in: PubMed
    Score: 0.010
  39. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
    View in: PubMed
    Score: 0.010
  40. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.009
  41. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.009
  42. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406.
    View in: PubMed
    Score: 0.009
  43. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2015 Apr; 17(4):463-72.
    View in: PubMed
    Score: 0.009
  44. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34.
    View in: PubMed
    Score: 0.009
  45. Use of stop-smoking medications in the United States before and after the introduction of varenicline. Addiction. 2015 Feb; 110(2):346-55.
    View in: PubMed
    Score: 0.009
  46. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.008
  47. Risk behaviors related to cigarette smoking among persons with spinal cord injury. Nicotine Tob Res. 2014 Feb; 16(2):224-30.
    View in: PubMed
    Score: 0.008
  48. Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res. 2014 Apr; 16(4):397-405.
    View in: PubMed
    Score: 0.008
  49. Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011). Tob Control. 2014 Mar; 23 Suppl 1:i48-53.
    View in: PubMed
    Score: 0.008
  50. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6.
    View in: PubMed
    Score: 0.008
  51. Left-digit price effects on smoking cessation motivation. Tob Control. 2014 Nov; 23(6):501-6.
    View in: PubMed
    Score: 0.008
  52. Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers. J Cancer Surviv. 2013 Mar; 7(1):44-54.
    View in: PubMed
    Score: 0.007
  53. Level of cigarette consumption and quit behavior in a population of low-intensity smokers--longitudinal results from the International Tobacco Control (ITC) survey in Mexico. Addict Behav. 2013 Apr; 38(4):1958-65.
    View in: PubMed
    Score: 0.007
  54. Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med. 2012 Dec; 43(6):590-600.
    View in: PubMed
    Score: 0.007
  55. Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
    View in: PubMed
    Score: 0.007
  56. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
    View in: PubMed
    Score: 0.006
  57. The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
    View in: PubMed
    Score: 0.006
  58. Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiency. Genet Test. 2008 Dec; 12(4):501-5.
    View in: PubMed
    Score: 0.006
  59. Internet-based intervention for mental health and substance use problems in disaster-affected populations: a pilot feasibility study. Behav Ther. 2006 Jun; 37(2):190-205.
    View in: PubMed
    Score: 0.005
  60. Genetic testing for alpha1-antitrypsin deficiency. Genet Med. 2004 Jul-Aug; 6(4):204-10.
    View in: PubMed
    Score: 0.004
  61. Physical activity and incident hypertension in black and white adults: the Atherosclerosis Risk in Communities Study. Prev Med. 1999 Mar; 28(3):304-12.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.